![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of innovative, small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate, CT1812, is an o... Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of innovative, small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate, CT1812, is an orally delivered, small molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.01 | -0.518134715026 | 1.93 | 2.12 | 1.83 | 112227 | 1.92916936 | CS |
4 | -0.25 | -11.5207373272 | 2.17 | 2.22 | 1.61 | 153016 | 1.86569108 | CS |
12 | 0.12 | 6.66666666667 | 1.8 | 2.95 | 1.61 | 148636 | 2.03213239 | CS |
26 | -0.08 | -4 | 2 | 2.95 | 1.61 | 181133 | 2.02736445 | CS |
52 | 0.15 | 8.47457627119 | 1.77 | 2.95 | 0.9001 | 150340 | 1.84047232 | CS |
156 | -10.23 | -84.1975308642 | 12.15 | 13.8 | 0.9001 | 163760 | 3.0160644 | CS |
260 | -10.23 | -84.1975308642 | 12.15 | 13.8 | 0.9001 | 163760 | 3.0160644 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions